These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15105146)

  • 1. Inhibitory activity of alkoxyalkyl and alkyl esters of cidofovir and cyclic cidofovir against orthopoxvirus replication in vitro.
    Keith KA; Wan WB; Ciesla SL; Beadle JR; Hostetler KY; Kern ER
    Antimicrob Agents Chemother; 2004 May; 48(5):1869-71. PubMed ID: 15105146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalkyl esters of cidofovir and cyclic cidofovir.
    Kern ER; Hartline C; Harden E; Keith K; Rodriguez N; Beadle JR; Hostetler KY
    Antimicrob Agents Chemother; 2002 Apr; 46(4):991-5. PubMed ID: 11897580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, metabolic stability and antiviral evaluation of various alkoxyalkyl esters of cidofovir and 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine.
    Ruiz J; Beadle JR; Buller RM; Schreiwer J; Prichard MN; Keith KA; Lewis KC; Hostetler KY
    Bioorg Med Chem; 2011 May; 19(9):2950-8. PubMed ID: 21493074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral treatment of cowpox and vaccinia virus infections in mice with ether lipid esters of cidofovir.
    Quenelle DC; Collins DJ; Wan WB; Beadle JR; Hostetler KY; Kern ER
    Antimicrob Agents Chemother; 2004 Feb; 48(2):404-12. PubMed ID: 14742188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alkoxyalkyl esters of cidofovir and cyclic cidofovir exhibit multiple-log enhancement of antiviral activity against cytomegalovirus and herpesvirus replication in vitro.
    Beadle JR; Hartline C; Aldern KA; Rodriguez N; Harden E; Kern ER; Hostetler KY
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2381-6. PubMed ID: 12121908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses.
    Smee DF; Sidwell RW; Kefauver D; Bray M; Huggins JW
    Antimicrob Agents Chemother; 2002 May; 46(5):1329-35. PubMed ID: 11959564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the antiviral activities of alkoxyalkyl and alkyl esters of cidofovir against human and murine cytomegalovirus replication in vitro.
    Wan WB; Beadle JR; Hartline C; Kern ER; Ciesla SL; Valiaeva N; Hostetler KY
    Antimicrob Agents Chemother; 2005 Feb; 49(2):656-62. PubMed ID: 15673748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous infections of mice with vaccinia or cowpox viruses and efficacy of cidofovir.
    Quenelle DC; Collins DJ; Kern ER
    Antiviral Res; 2004 Jul; 63(1):33-40. PubMed ID: 15196818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activities of alkoxyalkyl esters of cidofovir (CDV), cyclic CDV, and (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine against orthopoxviruses in cell monolayers and in organotypic cultures.
    Lebeau I; Andrei G; Dal Pozzo F; Beadle JR; Hostetler KY; De Clercq E; van den Oord J; Snoeck R
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2525-9. PubMed ID: 16801436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parapoxviruses are strongly inhibited in vitro by cidofovir.
    Nettleton PF; Gilray JA; Reid HW; Mercer AA
    Antiviral Res; 2000 Dec; 48(3):205-8. PubMed ID: 11164507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of potential anti-poxvirus agents.
    Kern ER
    Antiviral Res; 2003 Jan; 57(1-2):35-40. PubMed ID: 12615301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of nucleoside phosphonates and their analogs and prodrugs for inhibition of orthopoxvirus replication.
    Keith KA; Hitchcock MJ; Lee WA; Holý A; Kern ER
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2193-8. PubMed ID: 12821467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro.
    Williams-Aziz SL; Hartline CB; Harden EA; Daily SL; Prichard MN; Kushner NL; Beadle JR; Wan WB; Hostetler KY; Kern ER
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3724-33. PubMed ID: 16127046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of multiple- or single-dose cidofovir against vaccinia and cowpox virus infections in mice.
    Quenelle DC; Collins DJ; Kern ER
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3275-80. PubMed ID: 14506041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of cidofovir and cyclic HPMPC on lethal cowpox and vaccinia virus respiratory infections in mice.
    Smee DF; Bailey KW; Sidwell RW
    Chemotherapy; 2003 Jun; 49(3):126-31. PubMed ID: 12815205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal treatment of cowpox virus respiratory infections in mice with cidofovir.
    Smee DF; Bailey KW; Wong M; Sidwell RW
    Antiviral Res; 2000 Sep; 47(3):171-7. PubMed ID: 10974369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antiviral evaluation of alkoxyalkyl-phosphate conjugates of cidofovir and adefovir.
    Ruiz JC; Beadle JR; Aldern KA; Keith KA; Hartline CB; Kern ER; Hostetler KY
    Antiviral Res; 2007 Jul; 75(1):87-90. PubMed ID: 17367874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of lethal cowpox virus respiratory infections in mice with 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine and its orally active diacetate ester prodrug.
    Smee DF; Bailey KW; Sidwell RW
    Antiviral Res; 2002 May; 54(2):113-20. PubMed ID: 12062396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice.
    Smee DF; Bailey KW; Wong MH; Sidwell RW
    Antiviral Res; 2001 Oct; 52(1):55-62. PubMed ID: 11530188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of vaccinia virus replication by two small interfering RNAs targeting B1R and G7L genes and their synergistic combination with cidofovir.
    Vigne S; Duraffour S; Andrei G; Snoeck R; Garin D; Crance JM
    Antimicrob Agents Chemother; 2009 Jun; 53(6):2579-88. PubMed ID: 19307376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.